Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x100px

News > All

Total search results: 6897 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 35 36 37 ... 67 68 69  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
BRAIN AG. (3/7/18). "Press Release: BRAIN, AnalytiCon Discovery and Roquette Reach Major Milestone in DOLCE Program for Natural- based Sugar and Calorie Reduction in Food and Beverages Faster than Originally Expected". Zwingenberg, Potsdam & La Madeleine 2018-03-07
Selexis S.A.. (3/7/18). "Press Release: Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics". Geneva. 2018-03-07
Celgene Corporation. (3/6/18). "Press Release: Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy". Summit, NJ. 2018-03-06
Curetis N.V.. (3/6/18). "Press Release: Curetis Subsidiary Ares Genetics Wins Incubator Stay in Silicon Valley". Amsterdam & San Diego, CA & Holzgerlingen. 2018-03-06
Novartis AG. (3/6/18). "Press Release: Novartis' Xolair Recommended in New Global Chronic Urticaria Guideline". Basel. 2018-03-06
BRAIN AG. (3/6/18). "Press Release: BRAIN AG Establishes US Subsidiary to Strengthen Business Development in North America". Zwingenberg. 2018-03-06
Eurofins Scientific. (3/6/18). "Press Release: Eurofins Exceeds Its Recently-upgraded 2017 Objectives on a Strong Growth Momentum and Raises Its Objectives for 2018". 2018-03-06
BIA Separations d.o.o.. (3/5/18). "Press Release: BIA Separations and Nuvonis Technologies Partner to Support Vaccine and Gene Therapy Production". Ajdovšcina & Vienna. 2018-03-05
Heidelberg Pharma AG. (3/5/18). "Press Release: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive MultiTarget Research Agreement for the Development of Antibody Drug Conjugates". Ladenburg & Cambridge, MA. 2018-03-05
G1 Therapeutics, Inc.. (3/5/18). "Press Release: G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data Showing Robust Myelopreservation Benefits in Patients with Small Cell Lung Cancer". Research Triangle Park, NC. 2018-03-05
Addex Therapeutics S.A.. (3/5/18). "Press Release: Addex Secures Investor Commitment for CHF40 Million Capital Increase Following Successful Completion of Book Building Process". Geneva. 2018-03-05
ViraTherapeutics GmbH. (3/5/18). "Press Release: ViraTherapeutics Starts Second Oncolytic Virus Development Program with Boehringer Ingelheim". Innsbruck. 2018-03-05
Business France. (3/2/18). "Press Release: Biotechnology and Laboratory Technology from France at Analytica". 2018-03-02
Heidelberg Pharma AG. (3/1/18). "Press Release: Heidelberg Pharma Signs License Agreement with The University of Texas MD Anderson Cancer Center". Ladenburg. 2018-03-01
Affiris AG. (3/1/18). "Press Release: Affiris Announces Results of a Phase I Clinical Study Using Affitopes PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients". Vienna. 2018-03-01
Bruker Corporation. (3/1/18). "Press Release: Bruker Names Burkhard Prause, President of Bruker Energy & Supercon Technologies (BEST), an Executive Officer of Bruker Corporation". Billerica, MA. 2018-03-01
Basilea Pharmaceutica Ltd.. (3/1/18). "Press Release: Basilea Names Adesh Kaul as New Member of its Management Committee". Basel. 2018-03-01
Enzymicals AG. (3/1/18). "Press Release: Signed Cooperation Agreement. Special Chemical Manufacturers abcr GmbH and Enzymicals AG Want to Make Use of Synergies". Greifswald & Karlsruhe. 2018-03-01
R-Biopharm AG. (3/1/18). "Press Release: R-Biopharm AG & Bosch Healthcare Solutions Partner to Develop Molecular Diagnostics for Automated All-in-One Platform". Darmstadt & Waiblingen. 2018-03-01
BioMedPartners AG. (3/1/18). "Press Release: BioMedPartners Close Their New Healthcare Venture Fund BioMedInvest III at CHF 100 Million". Basel. 2018-03-01
Rentschler Biopharma SE. (2/28/18). "Press Release: Rentschler Biopharma SE Appoints Federico Pollano as Senior Vice President, Business Development". Laupheim. 2018-02-28
BRAIN AG. (2/28/18). "Press Release: BRAIN AG Starts the Financial Year 2017/18 with a Weak First Quarter". Zwingenberg. 2018-02-28
ERS Genomics Ltd.. (2/28/18). "Press Release: European Patent Office Grants Second Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications". Dublin. 2018-02-28
German Accelerator Life Sciences. (2/28/18). "Press Release: German Accelerator Life Sciences Appoints Vice President Germany". Berlin & Cambridge, MA. 2018-02-28
Thermo Fisher Scientific Inc.. (2/28/18). "Press Release: Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea". Waltham, MA. 2018-02-28
Novo Holdings A/S. (2/27/18). "Press Release: Novo Holdings Launches USD 165m Impact Fund to Combat Antimicrobial Resistance". Copenhagen. 2018-02-27
Basilea Pharmaceutica Ltd.. (2/27/18). "Press Release: Basilea Reports Significantly Improved Financial Results in 2017". Basel. 2018-02-27
Hume Brophy. (2/27/18). "Press Release: Hume Brophy International Healthcare Launches New Life Sciences Division". London. 2018-02-27
Selexis S.A.. (2/26/18). "Press Release: Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates". Geneva. 2018-02-26
Valneva S.E.. (2/26/18). "Press Release: Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate against Zika Virus". Gaithersburg, MD & Lyon. 2018-02-26
Bruker Corporation. (2/26/18). "Press Release: Bruker Highlights Innovative Analytical Solutions and Systems at Pittcon". Orlando, FL. 2018-02-26
Berlin Cures Holding AG. (2/26/18). "Press Release: Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study". Zug & Berlin. 2018-02-26
Miltenyi Biotec GmbH. (2/26/18). "Press Release: MolMed and Miltenyi Biotec. EMA Approves the Utilization of the CliniMACS Prodigy Equipment". Milan & Bergisch Gladbach. 2018-02-26
AiCuris Anti-infective Cures GmbH. (2/23/18). "Press Release: AiCuris’ Licensee MSD Launches Prevymis (letermovir) in Germany". Wuppertal. 2018-02-23
Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel. 2018-02-23
BCNP Consultants GmbH. (2/23/18). "Press Release: More than 1,200 Meetings at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-02-23
Qiagen N.V.. (2/23/18). "Press Release: Qiagen Opens Shared Services Center in Taguig City, Manila". Manila. 2018-02-23
Streck, Inc.. (2/23/18). "Press Release: Streck, Inc. Files Suit against Cenata GmbH for Infringement of Its European Patent". La Vista, NE. 2018-02-23
BRAIN AG. (2/22/18). "Press Release: BRAIN AG Expands Patent Protection for Unique Taste Cell Technology to Europe". 2018-02-22
Bruker Corporation. (2/22/18). "Press Release: Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM²". Ettlingen. 2018-02-22
Medigene AG. (2/21/18). "Press Release: Medigene Receives Approvals for Its First Clinical Trial with TCR Therapy MDG1011". Planegg. 2018-02-21
Basilea Pharmaceutica Ltd.. (2/21/18). "Press Release: Basilea's CEO Ronald Scott Will Retire. Chief Commercial Officer David Veitch Named as Successor – Changes in the Board of Directors". Basel. 2018-02-21
Bruker Corporation. (2/21/18). "Press Release: Bruker Announces Resignation of Chief Financial Officer and Appointment of Principal Accounting Officer". Billerica, MA. 2018-02-21
G1 Therapeutics, Inc.. (2/21/18). "Press Release: G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights". Research Triangle Park, NC. 2018-02-21
Merck KGaA. (2/21/18). "Press Release: Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia". Darmstadt. 2018-02-21
Cullinan Oncology, LLC. (2/20/18). "Press Release: Cullinan Oncology and MAB Discovery Announce Collaboration to Develop Novel Antibody-Based Therapeutics". Cambridge, MA & Neuried. 2018-02-20
Bruker Corporation. (2/20/18). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. 2018-02-20
Minoryx Therapeutics S.L.. (2/20/18). "Press Release: Minoryx Therapeutics Spins Off SEE-Tx Platform into New Company, Gain Therapeutics". Mataró, Barcelona & Lugano. 2018-02-20
Siemens AG. (2/19/18). "Press Release: Siemens Plans IPO of Siemens Healthineers AG in the First Half of Calendar Year 2018 [Not for United States, Australia, Canada or Japan]". Erlangen & Munich. 2018-02-19
Avillion LLP. (2/16/18). "Press Release: Avillion Advances Co-development Programme with Merck. IND Now Open for Phase 2 Study of M1095, an anti-IL-17 A/F Nanobody in Psoriasis". London. 2018-02-16
Pieris Pharmaceuticals, Inc.. (2/16/18). "Press Release: Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares". Boston, MA. 2018-02-16
Affimed N.V.. (2/15/18). "Press Release: Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. 2018-02-15
Addex Therapeutics S.A.. (2/15/18). "Press Release: Addex Launches CHF40 million Capital Increase with Commitments from Specialist US Healthcare Investors". Geneva. 2018-02-15
Roche. (2/15/18). "Press Release: Roche to Acquire Flatiron Health to Accelerate Industry-wide Development and Delivery of Breakthrough Medicines for Patients with Cancer". Basel. 2018-02-15
Merck KGaA. (2/15/18). "Press Release: Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer [Not intended for UK-based media]". Darmstadt. 2018-02-15
ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. 2018-02-15
Cell Medica Ltd.. (2/15/18). "Press Release: Cell Medica Announces the Appointment of Kevin Boyle as Chief Financial Officer". 2018-02-15
Bruker Corporation. (2/14/18). "Press Release: The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology". Billerica, MA. 2018-02-14
Recipharm AB. (2/14/18). "Press Release: Recipharm Appoints President Development Services to Drive End to End Offering". 2018-02-14
Affimed N.V.. (2/13/18). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. 2018-02-13
Gilde Healthcare Partners. (2/13/18). "Press Release: Gilde Healthcare Company RAD-x Continues Buy & Build with Acquisition of Swiss Medical Imaging Centers". Utrecht. 2018-02-13
Sciomics GmbH. (2/12/18). "Press Release: Sciomics Participates in Collaborative Clinical Trials for the Treatment of Metaphyseal Chondrodysplasia Type Schmid (MCDS)". Heidelberg. 2018-02-12
Affimed N.V.. (2/12/18). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. 2018-02-12
Lonza Group AG. (2/12/18). "Press Release: Lonza Expands Cell-Culture Portfolio with Quasi Vivo System". Basel. 2018-02-12
Pieris Pharmaceuticals, Inc.. (2/9/18). "Press Release: Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration". Boston, MA & Bothell, WA. 2018-02-09
Boehringer Ingelheim. (2/9/18). "Press Release: Boehringer Ingelheim Refocuses PDE9 Inhibition Brain Research on Schizophrenia Following Results from Phase II Alzheimer’s Trials". Ingelheim. 2018-02-09
Bruker Corporation. (2/8/18). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2017 Financial Results". Billerica, MA. 2018-02-08
Fluidigm Corporation. (2/8/18). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress". South San Francisco, CA. 2018-02-08
Genedata AG. (2/8/18). "Press Release: Genedata Bioprocess Licensed to Pfizer Inc.". Basel. 2018-02-08
Lonza Group Ltd.. (2/8/18). "Press Release: Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines". Basel & South San Francisco, CA. 2018-02-08
University of Bayreuth. (2/8/18). "Press Release: Innovative Research Infrastructure with a Global Reputation. The Northern Bavarian NRM Centre Repositions Itself". 2018-02-08
c-LEcta GmbH. (2/8/18). "Press Release: c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company". 2018-02-08
Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. 2018-02-07
Addex Therapeutics S.A.. (2/7/18). "Press Release: Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management". Geneva. 2018-02-07
Analytik Jena AG. (2/7/18). "Press Release: Laboratory Automation Solution Designed to Boost Productivity Showcased at SLAS 2018". San Diego, CA & Jena. 2018-02-07
Lonza Group Ltd.. (2/7/18). "Press Release: Lonza Partners with Prolog Ventures to Establish VC Fund to Invest in Consumer Health and Wellness Startups". Basel. 2018-02-07
Sanofi S.A.. (2/7/18). "Press Release: Sanofi Delivers 2017 Business EPS(1) in Line with Guidance". Paris. 2018-02-07
ProBioGen AG. (2/7/18). "Press Release: ProBioGen and Teva Sign License Agreement on Human Artificial Lymph Node Technology". Berlin. 2018-02-07
ImmunoQure AG. (2/6/18). "Press Release: Servier and ImmunoQure AG Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody". Paris & Düsseldorf. 2018-02-06
Genedata AG. (2/6/18). "Press Release: Genedata Announces New Solution for NGS-Based Biosafety Assessment". Basel. 2018-02-06
Idorsia Ltd.. (2/6/18). "Press Release: Idorsia Announces Financial Results for 2017 – Company Off to a Great Start – 4 Compounds to Enter Phase 3 Development". Allschwil. 2018-02-06
InflaRx N.V.. (2/6/18). "Press Release: InflaRx Announces Appointment of Tony Gibney to Its Board of Directors". Jena. 2018-02-06
Selvita S.A.. (2/6/18). "Press Release: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer". Kraków. 2018-02-06
Sophia Genetics S.A.. (2/6/18). "Press Release: Sophia Genetics Announces CE-IVD Marking of Its Genomic Test for Leukemia Detection". Lausanne. 2018-02-06
Faron Pharmaceuticals Oy. (2/5/18). "Press Release: Faron Establishes Second Traumakine Manufacturing Site". Turku. 2018-02-05
Addex Therapeutics S.A.. (2/5/18). "Press Release: Addex Provides Key Financial Indicators and Trading Update. Cash Position of CHF6.5 million as of 31 January 2018". Geneva. 2018-02-05
SGS S.A.. (2/2/18). "Press Release: SGS Acquires TraitGenetics GmbH, Germany". 2018-02-02
Genedata AG. (2/2/18). "Press Release: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer". Basel. 2018-02-02
4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. 2018-02-01
Medigene AG. (2/1/18). "Press Release: Medigene Strengthens Its Patent Portfolio with a US Patent on a Tagged TCR". Planegg. 2018-02-01
Lab Automation Network (LAN). (2/1/18). "Press Release: Cytosurge AG and Lab Automation Network Announce Partnership for Automated Single-cell Biology Applications". 2018-02-01
Life Science Inkubator GmbH. (2/1/18). "Press Release: Life Science Inkubator (LSI) Bonn for the First Time Supports Pharma Industry Spin-out". 2018-02-01
Miltenyi Biotec GmbH. (2/1/18). "Press Release: Cancer Coaching for the Immune System. Novel Cell Therapy Will Teach Immune Cells How to Fight Cancer". Teterow. 2018-02-01
Arnold & Porter LLP. (2/1/18). "Press Release: Announcing Arnold & Porter". 2018-02-01
Affimed N.V.. (2/1/18). "Press Release: Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas". Heidelberg. 2018-02-01
Qiagen N.V.. (1/31/18). "Press Release: Qiagen Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing". Germantown, MD & Hilden. 2018-01-31
Genedata AG. (1/31/18). "Press Release: Genedata Announces Genedata Screener for Massive Mechanistic Analysis". Basel. 2018-01-31
Analytik Jena AG. (1/31/18). "Press Release: SLAS 2018 — Modular Liquid Handling System CyBio FeliX Automates New Process for Nucleic Acid Extraction". Jena. 2018-01-31
Lonza Group AG. (1/31/18). "Press Release: Lonza Reports Record-breaking Full-year Results with Double-digit Lonza Standalone Sales Growth and More than 26% CORE EBIT Growth in a Major Transformational Year". Basel. 2018-01-31
Sanofi S.A.. (1/31/18). "Press Release: Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment". Paris & Geneva. 2018-01-31
next pagenext page 1 2 3 ... 35 36 37 ... 67 68 69  next pagenext page


Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Campus Berlin-Buch GmbH GMP Basic Course Online 650x300px

» top